OPTIMIZATION OF RECOMBINANT ANTIBODY PRODUCTION IN CHO CELLS

The optimization of recombinant antibody production from Chinese hamster ovary (CHO) cells remains a paramount challenge for the biopharmaceutical industry. A variety of strategies can be employed to antibody titer, comprising process parameter optimization, genetic engineering, and the use of perfusion processes. Fine-tuning growth parameters pl